RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @Pharmaforkids: This is fascinating - and chimes with the clinical and societal experiences, noting increased anxiety in paediatric age…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
This is fascinating - and chimes with the clinical and societal experiences, noting increased anxiety in paediatric age patients, but sadly only those age 18+ included so cant prove it. Would be very interesting (to me at least) to see if also replicated
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
RT @ArcherCS_: Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodi…
Prescribing for #anxiety - substantial increases in incident prescribing in 18-24 year olds in all drug classes inc. benzodiazepines. Out in @BJGPjournal online first. @capcbristol @NIHRSPCR @ARC_West @BristolBRC https://t.co/kXk1bLvYko
The rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using CPRD | British Journal of General Practice https://t.co/FTGPSzuTE8
RT @maidment_dr: Increase in prescribing for anxiety in UK primary care https://t.co/UWCyZ9AfOF Paper by @ArcherCS_ @DrKMTurner and colle…
RT @maidment_dr: Increase in prescribing for anxiety in UK primary care https://t.co/UWCyZ9AfOF Paper by @ArcherCS_ @DrKMTurner and colle…
RT @maidment_dr: Increase in prescribing for anxiety in UK primary care https://t.co/UWCyZ9AfOF Paper by @ArcherCS_ @DrKMTurner and colle…
RT @maidment_dr: Increase in prescribing for anxiety in UK primary care https://t.co/UWCyZ9AfOF Paper by @ArcherCS_ @DrKMTurner and colle…
Increase in prescribing for anxiety in UK primary care https://t.co/UWCyZ9AfOF Paper by @ArcherCS_ @DrKMTurner and colleagues. @CMHPCommunity @WePharmacists @sapcacuk @capcbristol @MHRIncubator @HYMS_APC